2021
DOI: 10.1155/2021/6695806
|View full text |Cite
|
Sign up to set email alerts
|

Idiopathic Sclerosing Encapsulating Peritonitis in a Patient with Atypical Symptoms and Imaging Findings

Abstract: Sclerosing encapsulating peritonitis is a rare condition caused by a fibrotic membrane covering the small bowel which may lead to abdominal pain or obstruction. The cause may be primary and idiopathic or secondary to several diseases, treatments, and/or medications. The condition typically presents with bowel obstruction, and only one previous case has described ascites as the presenting sign. Sclerosing encapsulating peritonitis is typically diagnosed intraoperatively. We present a case of a patient who prese… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 15 publications
0
4
0
Order By: Relevance
“…The pathophysiology of SEP has been reported as four different stages: a presclerosing encapsulating peritonitis, an inflammatory phase, a progressive phase, and a fibrotic phase. The fibrotic phase has been affiliated with the formation of a thick fibrotic membrane encasing the abdominal content and causing small bowel obstruction as in our case [ 4 ].…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…The pathophysiology of SEP has been reported as four different stages: a presclerosing encapsulating peritonitis, an inflammatory phase, a progressive phase, and a fibrotic phase. The fibrotic phase has been affiliated with the formation of a thick fibrotic membrane encasing the abdominal content and causing small bowel obstruction as in our case [ 4 ].…”
Section: Discussionmentioning
confidence: 94%
“…Clinical symptoms are nonspecific and include abdominal pain, abdominal fullness, nausea, vomiting, anorexia, pyrexia, change in bowel habit, and intestinal obstruction, which makes preoperative diagnosis difficult [ 4 ]. However, with the arrival of latest imaging technology like high-resolution CT or magnetic resonance imaging, distinguishing SEP from other peritonitis seems possible [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…In asymptomatic patients without signs of intestinal obstruction, the use of immunosuppressants such as colchicine, an mRNA expression inhibitor with antiinflammatory properties, and azathioprine, a purine synthesis inhibitor that reduces the inflammatory process, is recommended 5,18,27,28 . In cases in which patients have advanced peritoneal fibrosis, anti-fibrotic therapy in addition to the administration of immunosuppressants is necessary, usually Tamoxifen, a selective estrogen receptor whose main function is to inhibit the production of fibroblasts 15,22,26 . In refractory cases, the administration of corticosteroids is suggested to inhibit collagen synthesis and maturation of the encapsulating membrane, as well as to suppress the inflammatory process in the peritoneum 5,27 .…”
Section: Discussionmentioning
confidence: 99%
“…In addition, early testing of his large volume ascites revealed an elevated SAAG, which is most often caused by liver disease, but in this case, was likely due to prehepatic vascular compression by thickened peritoneum. Low SAAG ascites are sometimes seen with SEP and this type of portal vascular compression is not readily identified on CT. 3,4 In this case, the subsequent development of low SAAG ascites may have been the result of an increased burden of malignant and inflammatory cells in the peritoneum.…”
Section: Commentarymentioning
confidence: 91%